Polymerase Chain Reaction Testing: Selected Indications — CPB 0650 | AETNA Coverage Update

TL;DR: Aetna, a CVS Health company, modified CPB 0650 — its PCR testing coverage policy — effective January 29, 2026. If your team bills any of the 200+ CPT codes under this bulletin, your medical necessity documentation requirements just changed.

CPB 0650 governs qualitative and quantitative polymerase chain reaction (PCR) testing across infectious disease, oncology, genetic testing, and transplant medicine. This update touches codes across an enormous range of specialties — from 87476 for Borrelia burgdorferi to 81206–81208 for BCR/ABL1 translocation analysis to 0339U for prostate oncology mRNA profiling. The sheer breadth of this policy means almost every lab billing team, oncology practice, or infectious disease group has exposure here.

---

Quick-Reference Table

Field	Detail Copy
Payer	Aetna, a CVS Health company
Policy	Polymerase Chain Reaction Testing: Selected Indications
Policy Code	CPB 0650
Change Type	Modified
Effective Date	January 29, 2026
Impact Level	High
Specialties Affected	Clinical laboratory, infectious disease, oncology, transplant medicine, OB/GYN, molecular pathology, genetics
Key Action	Audit your active CPT codes against CPB 0650's indication-specific criteria before billing any PCR claim to Aetna

---

Aetna PCR Testing Coverage Criteria and Medical Necessity Requirements 2026

The Aetna PCR testing coverage policy is not a simple "covered or not covered" list. It's a matrix of conditions, specimen types, patient populations, and clinical contexts — and each one can flip a covered code to a denied claim.

Medical necessity under CPB 0650 is indication-specific. Aetna covers PCR testing when the clinical scenario matches a defined criterion. A code like 87640 for Staphylococcus aureus might be covered in one context and denied in another — same code, different patient situation.

Here's where billing teams run into trouble: the policy covers qualitative PCR for some indications and quantitative PCR for others. Submitting the wrong test type — even for a covered pathogen — can trigger a claim denial. Know which format each indication requires before the claim goes out.

Key Medical Necessity Criteria by Indication

Infectious Disease — Symptomatic and Exposure-Based Criteria

For avian influenza A (H5N1), Aetna requires both consistent symptoms and documented travel or contact with persons or birds from an affected country within 10 days of symptom onset. Both criteria must be in the record. One without the other does not satisfy medical necessity.

For Bordetella pertussis (whooping cough), covered codes are applicable only when symptoms — paroxysmal cough, inspiratory whoop, post-tussive vomiting, or apnea in infants under one year — developed fewer than 21 days before testing. Symptom duration is a hard cutoff here. Document the onset date.

For bacterial vaginosis (BV), Aetna covers PCR on vaginal specimens in symptomatic patients only. PCR testing on urine for BV diagnosis is not medically necessary under this coverage policy. Neither is PCR testing in asymptomatic male sex partners.

Transplant and Immunocompromised Populations

BK polyomavirus PCR is covered for transplant recipients on immunosuppressive therapy and for persons with immunosuppressive diseases like HIV/AIDS-associated immune complex glomerulonephritis. This is one area where the indication is relatively clear — but you still need the diagnosis codes to match.

Oncology PCR Testing

BCR/ABL1 translocation analysis — billed as 81206, 81207, or 81208 — is covered under CPB 0650 for chronic myelogenous leukemia (CML) and related conditions. The BRAF mutation analysis code 81210 is covered for hairy cell leukemia and colon cancer/melanoma. ALK testing is covered as an alternative to FISH when selecting patients for ALK inhibitor therapy.

Coverage criteria under CPB 0650 apply at the policy level. Verify individual member eligibility and plan-level benefits separately. Before billing high-cost molecular oncology codes like 0339U (prostate cancer mRNA profiling) or 0040U (BCR/ABL1 quantitative), confirm the member's plan-level benefits directly.

---

Aetna PCR Testing Exclusions and Non-Covered Indications

Several specific exclusions appear directly in this coverage policy.

BV PCR on urine specimens — not medically necessary. Aetna covers vaginal specimen PCR for BV diagnosis in symptomatic patients, but urine is explicitly excluded.

BV PCR in asymptomatic male sex partners — not medically necessary. Even if the female partner has a confirmed BV diagnosis, PCR testing of an asymptomatic male partner is not covered.

Specimen type mismatches — this is the category that generates quiet denials. Some indications are limited to specific specimen types (e.g., biopsy specimens for Borrelia mayonii in suspected Lyme arthritis). If your lab bills a blood draw when the policy requires synovial fluid or tissue, the claim fails on medical necessity grounds — even if the underlying diagnosis is valid.

Geographic limitations on coverage — Borrelia mayonii PCR is covered only for patients who live in or have traveled to Minnesota or Wisconsin. If the member's address or travel history doesn't meet this criterion, the test is not covered.

---

Coverage Indications at a Glance

---

Aetna PCR Testing Billing Guidelines and Action Items 2026

PCR testing billing errors almost always come from the same source: the claim goes out with the right code but the wrong context. Use these steps to clean that up before January 29, 2026 exposures start showing up in your denial queue.

Copy Action Items

---

CPT, HCPCS, and ICD-10 Codes for PCR Testing Under CPB 0650

Covered CPT Codes (When Selection Criteria Are Met)

Note: The policy lists 201 total CPT codes. The codes above represent those explicitly provided in the policy data. Review the full CPB 0650 bulletin at Aetna's website for the complete code list.

Not Covered / Experimental Codes

The policy does not assign specific CPT codes to a "not covered" or "experimental" group. Non-coverage under CPB 0650 is indication-driven, not code-driven. A code billed with a non-covered indication — such as BV PCR on urine, or Borrelia mayonii outside the geographic criteria — will deny regardless of the code itself.

Key ICD-10-CM Diagnosis Codes

The policy references 3,160 ICD-10-CM codes. Specific codes were not individually listed in the source data provided. Pull the full diagnosis code list directly from CPB 0650 on Aetna's website and map each active PCR claim to a covered diagnosis.

---